bf/NASDAQ:ADTX_icon.jpeg

NASDAQ:ADTX

Aditxt, Inc.

  • Stock

USD

Last Close

5.89

06/11 22:27

Market Cap

3.33M

Beta: 1.57

Volume Today

72.38K

Avg: 615.10K

PE Ratio

−0.02

PFCF: −0.33

    Description

    Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based tec...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1000-800-600-400-2002020-06-302021-08-122023-03-132024-03-192024-11-12

    Revenue (Estimate*)

    100K200K300K400K2020-06-302021-08-122023-03-132024-03-192024-11-12

    *Estimate based on analyst consensus